Long- Versus Short-Acting ??2-Agonists
- 1 February 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (2) , 207-222
- https://doi.org/10.2165/00003495-199447020-00001
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- Questions about inhaled β2-adrenoceptor agonists in asthmaTrends in Pharmacological Sciences, 1992
- Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in childrenJournal of Allergy and Clinical Immunology, 1992
- The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hoursJournal of Allergy and Clinical Immunology, 1992
- Risks Versus Benefits of Inhaled ??2-Agonists in the Management of AsthmaDrug Safety, 1992
- Salmeterol XinafoateDrugs, 1991
- FormoterolDrugs, 1991
- Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.BMJ, 1990
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990
- Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol1Journal of Allergy and Clinical Immunology, 1990
- Clinical Pharmacokinetics of ??-AgonistsClinical Pharmacokinetics, 1990